IHS Chemical Week

EnviroTech :: Regulatory :: Regulatory: Toxics

EPA proposes assessment review model for endocrine

1:49 PM MST | January 3, 2013 | —Kara Sissell

EPA says it is working on a “state of the science” paper to update its research on low-dose health effects for endocrine disruptors. The findings will provide information to help inform how EPA assesses the safety of chemicals by determining if current methods adequately portray possible links between levels of exposure and adverse health effects, the agency says. Risk assessments for low-dose effects—or nonmonotonic dose response curves (NMDRCs)—for endocrine disruptors have generated considerable differences of opinion among scientists...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa